Celcuity’s (NASDAQ:CELC) lock-up period is set to expire on Monday, March 19th. Celcuity had issued 2,400,000 shares in its IPO on September 20th. The total size of the offering was $22,800,000 based on an initial share price of $9.50. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.
Celcuity (CELC) opened at $15.92 on Wednesday. Celcuity has a 52-week low of $11.10 and a 52-week high of $22.73.
Hedge funds have recently modified their holdings of the company. Deutsche Bank AG bought a new stake in shares of Celcuity in the fourth quarter worth about $116,000. Millennium Management LLC bought a new stake in shares of Celcuity in the fourth quarter worth about $231,000. Royce & Associates LP bought a new stake in shares of Celcuity in the third quarter worth about $1,371,000. BlackRock Inc. bought a new stake in shares of Celcuity in the fourth quarter worth about $2,329,000. Finally, Gagnon Securities LLC bought a new stake in shares of Celcuity in the third quarter worth about $2,749,000. 13.79% of the stock is currently owned by hedge funds and other institutional investors.
Celcuity, Inc is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it.
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.